In‐Jin Jang
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 58
- Pharmacogenetics and Drug Metabolism 48
- Antibiotics Pharmacokinetics and Efficacy 30
-
- Diabetes Treatment and Management 37
- Co-authors
- Kyung‐Sang YuJoo‐Youn ChoSeo Hyun YoonKyoung Soo LimJae‐Yong ChungSeungHwan LeeHyeong‐Seok LimSang-Goo Shin
- Journals
- Clinical Therapeutics (28 papers)Drug Design Development and Therapy (25 papers)Clinical and Translational Science (12 papers)British Journal of Clinical Pharmacology (12 papers)Scientific Reports (10 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
In‐Jin Jang
290 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 144
- Pharmacology 1.2k
- Oncology 1.6k
- Gastroenterology 311
- Pharmacology 808
- Pediatrics, Perinatology and Child Health 777
Countries citing papers authored by In‐Jin Jang
This map shows the geographic impact of In‐Jin Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Jin Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Jin Jang more than expected).
Fields of papers citing papers by In‐Jin Jang
This network shows the impact of papers produced by In‐Jin Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Jin Jang. The network helps show where In‐Jin Jang may publish in the future.
Co-authors
The 25 scholars most cited alongside In‐Jin Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 62 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 55 | |
| 14 | 2018 | 6 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 12 | |
| 17 | 2017 | 3 | |
| 18 | 2006 | 55 | |
| 19 | No associations between 5-HTT, 5-HT2A gene polymorphisms and obsessive-compulsive disorder in a Korean population | 2006 | 3 |
| 20 | Pharmacokinetics of amitriptyline demethylation; a crossover study with single doses of amitriptyline and nortriptyline | 1990 | 1 |
About In‐Jin Jang
In‐Jin Jang is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Pharmacology, Gastroenterology and Oncology, having authored 306 papers that have together received 5.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (48 papers), Drug Transport and Resistance Mechanisms (43 papers), Diabetes Treatment and Management (37 papers), Pharmacological Effects and Toxicity Studies (34 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers), Epilepsy research and treatment (21 papers), Gastroesophageal reflux and treatments (18 papers) and Analytical Methods in Pharmaceuticals (16 papers). The work is most often cited by research in Pharmacology (1.2k citations), Oncology (1.6k citations), Gastroenterology (311 citations), Pharmacology (808 citations) and Pediatrics, Perinatology and Child Health (777 citations). In‐Jin Jang has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kyung‐Sang Yu, Joo‐Youn Cho, Seo Hyun Yoon, Kyoung Soo Lim, Jae‐Yong Chung, SeungHwan Lee, Hyeong‐Seok Lim, Sang-Goo Shin, Sang‐Goo Shin and SoJeong Yi. Their work appears in journals such as Clinical Therapeutics, Drug Design Development and Therapy, Clinical and Translational Science, British Journal of Clinical Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.